Published in Infect Immun on April 01, 2003
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens. Clin Microbiol Rev (2003) 0.95
The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis. Virulence (2013) 0.87
Invasion of endothelial cells by tissue-invasive M3 type group A streptococci requires Src kinase and activation of Rac1 by a phosphatidylinositol 3-kinase-independent mechanism. J Biol Chem (2009) 0.84
M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes. Microbiology (2007) 0.81
Positive feedback loops for factor V and factor VII activation supply sensitivity to local surface tissue factor density during blood coagulation. Biophys J (2011) 0.79
Potential mechanisms underlying the acute lung dysfunction and bacterial extrapulmonary dissemination during Burkholderia cenocepacia respiratory infection. Respir Res (2010) 0.78
A novel role for pro-coagulant microvesicles in the early host defense against streptococcus pyogenes. PLoS Pathog (2013) 0.78
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med (1989) 8.01
Invasive group A streptococcus infections. Clin Infect Dis (1992) 4.82
Streptococcal infections of skin and soft tissues. N Engl J Med (1996) 4.78
Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA (1993) 3.70
Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A (1999) 2.98
Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis (1992) 2.09
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest (1993) 2.00
Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost (1983) 1.96
Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood (1998) 1.79
Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun (1987) 1.72
Staging of the baboon response to group A streptococci administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response patterns. Clin Infect Dis (1999) 1.71
Contact activation in shock caused by invasive group A Streptococcus pyogenes. Crit Care Med (2000) 1.60
The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis. Crit Care Med (2001) 1.57
Review: infectious diseases and coagulation disorders. J Infect Dis (1999) 1.50
Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol (1995) 1.48
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med (2001) 1.41
Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med (2001) 1.39
Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes. Infect Immun (2002) 1.31
Mediation of adherence of streptococci to human endothelial cells by complement S protein (vitronectin). Infect Immun (1988) 1.27
Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14. Infect Immun (1995) 1.15
Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J Infect Dis (1996) 1.10
Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells. Infect Immun (1999) 0.98
The TF:VIIa complex: clinical significance, structure-function relationships and its role in signaling and metastasis. Thromb Haemost (2001) 0.96
Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis. Crit Care Med (2000) 0.96
Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis (1994) 0.94
The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost (2001) 0.92
The hemopexin-type repeats of human vitronectin are recognized by Streptococcus pyogenes. Biochem Biophys Res Commun (1997) 0.87
Kallikrein-kinin system activation in streptococcal toxic shock syndrome. Clin Infect Dis (2000) 0.83
Mechanism of tissue factor activation on cells. Blood Coagul Fibrinolysis (1998) 0.83
Mononuclear phagocyte thromboplastin and endotoxin in patients with secondary bacterial peritonitis. Scand J Gastroenterol (1987) 0.83
Variations among clinical isolates of Staphylococcus aureus to induce expression of E-selectin and ICAM-1 in human endothelial cells. FEMS Immunol Med Microbiol (2002) 0.80
Limb salvage for streptococcal gangrene of the extremity. Am J Surg (1998) 0.78
Type-specific opsonophagocytosis of group A Streptococcus by use of a rapid chemiluminescence assay. J Infect Dis (1999) 0.77
Streptococcal infections of skin and soft tissues. N Engl J Med (1996) 4.78
Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis (1992) 2.91
Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol (1995) 2.79
Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis (2006) 2.52
Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens. Mol Microbiol (1994) 2.37
Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis (1992) 2.09
Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol (1991) 2.07
Creutzfeldt-Jakob disease. The neuropathology of a transmission experiment. Brain (1969) 1.96
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis (1995) 1.88
Inability of the Chemstrip LN compared with quantitative urine culture to predict significant bacteriuria. J Clin Microbiol (1986) 1.75
Comparison of the MicroScan system with the API Staph-Ident system for species identification of coagulase-negative staphylococci. J Clin Microbiol (1986) 1.75
Cryptogenic drop attacks: an affliction of women. Br Med J (1973) 1.72
Staging of the baboon response to group A streptococci administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response patterns. Clin Infect Dis (1999) 1.71
Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis (1996) 1.71
Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis (1987) 1.61
Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes. J Infect Dis (1987) 1.56
Antibiotic susceptibilities of human isolates of Pasteurella multocida. Antimicrob Agents Chemother (1979) 1.44
Haemophilus influenzae pneumonia in adults. JAMA (1977) 1.41
False no-growth blood cultures in pneumococcal pneumonia. J Clin Microbiol (1980) 1.40
Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice. J Gen Intern Med (1997) 1.36
Chromosomal instability in the descendants of unirradiated surviving cells after alpha-particle irradiation. Proc Natl Acad Sci U S A (1998) 1.35
Persistent acylation of high-molecular-weight penicillin-binding proteins by penicillin induces the postantibiotic effect in Streptococcus pyogenes. J Infect Dis (1994) 1.32
Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1. Mol Microbiol (1994) 1.22
Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob Agents Chemother (1987) 1.22
Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun (1994) 1.20
Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. J Infect Dis (1993) 1.20
Measurement of human postural sway. Proc R Soc Med (1971) 1.18
Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency. N Engl J Med (1984) 1.18
The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. J Biol Chem (1989) 1.16
Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest (1997) 1.16
Primary sternal osteomyelitis. West J Med (1989) 1.13
Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J Infect Dis (2000) 1.12
Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol Med Microbiol (1993) 1.11
Spontaneous gas gangrene at a site of remote injury--localization due to circulating antitoxin. West J Med (1988) 1.08
Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J Infect Dis (2000) 1.07
Construction and virulence testing of a collagenase mutant of Clostridium perfringens. Microb Pathog (2000) 1.06
Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J Pharmacol Exp Ther (1992) 1.04
Epidemiologic investigation of methicillin resistant Staphylococcus aureus in a burn unit. Mil Med (1978) 1.04
Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera. J Infect Dis (1999) 1.03
Progressive myoclonus epilepsy without Lafora bodies. J Neurol Neurosurg Psychiatry (1969) 1.02
Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. Clin Infect Dis (1996) 1.02
Comparison of adherence to and penetration of a human laryngeal epithelial cell line by group A streptococci of various M protein types. FEMS Immunol Med Microbiol (1999) 1.02
Chronic familial vascular encephalopathy. Lancet (1977) 1.01
Pseudallescheria boydii infections treated with ketoconazole. Clinical evaluations of seven patients and in vitro susceptibility results. Chest (1984) 1.00
Stimulation of human neutrophil chemiluminescence by soluble immune complexes and antibodies to neutrophils. J Lab Clin Med (1981) 1.00
Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope (1980) 1.00
The first case of Pasteurella canis bacteremia: a cirrhotic patient with an open leg wound. Infection (2010) 0.99
Direct comparison between protons and alpha-particles of the same LET: I. Irradiation methods and inactivation of asynchronous V79, HeLa and C3H 10T1/2 cells. Int J Radiat Biol (1992) 0.98
Standardization of a rapid microbiologic assay for aminoglycosides using Enterobacter cloacae. Am J Clin Pathol (1978) 0.98
Use of trehalose-mannitol-phosphatase agar to differentiate Staphylococcus epidermidis and Staphylococcus saprophyticus from other coagulase-negative staphylococci. J Clin Microbiol (1984) 0.97
Induction and rejoining of DNA double-strand breaks in V79-4 mammalian cells following gamma- and alpha-irradiation. Int J Radiat Biol (1993) 0.96
Clinical courses of seven survivors of Clostridium septicum infection and their immunologic responses to alpha toxin. Clin Infect Dis (1994) 0.93
Familial transmission of a serious disease--producing group A streptococcus clone: case reports and review. Clin Infect Dis (1997) 0.93
Halophilic Vibrio sepsis. South Med J (1980) 0.92
Opsonization of T1M1 group A Streptococcus: dynamics of antibody production and strain specificity. Clin Infect Dis (2001) 0.92
Induction and rejoining of DNA double-strand breaks in Chinese hamster V79-4 cells irradiated with characteristic aluminum K and copper L ultrasoft X rays. Radiat Res (1997) 0.92
Effects of Clostridium perfringens recombinant and crude phospholipase C and theta-toxin on rabbit hemodynamic parameters. J Infect Dis (1995) 0.91
Impotence in farm workers using toxic chemicals. Br Med J (1970) 0.89
Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL. Brain (2007) 0.89
Spontaneous Rupture of Axillary Artery. Ann Surg (1945) 0.88
Clostridium perfringens phospholipase C-induced platelet/leukocyte interactions impede neutrophil diapedesis. J Med Microbiol (2006) 0.88
Tests for Huntington's chorea. N Engl J Med (1971) 0.87
Diabetic ketoacidosis associated with aripiprazole. Diabet Med (2005) 0.87
Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens. Antimicrob Agents Chemother (1987) 0.87
Epilepsy in the accident and emergency department. Br J Hosp Med (1994) 0.86
Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis. Antimicrob Agents Chemother (1987) 0.85
Frequencies of complex chromosome exchange aberrations induced by 238Pu alpha-particles and detected by fluorescence in situ hybridization using single chromosome-specific probes. Int J Radiat Biol (1995) 0.85
Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome. Clin Infect Dis (1998) 0.83
Fibrogenic potential of intratracheally instilled quartz, ferric oxide, fibrous glass, and hydrated alumina in hamsters. Toxicol Pathol (1985) 0.83
A natural infection of Fascioloides magna in a llama (Lama glama). J Parasitol (1988) 0.83
Chlorthalidone-associated neutropenia. West J Med (1982) 0.83
Hepatic necrosis following halothane anesthesia in goats. J Am Vet Med Assoc (1986) 0.82
Experimental techniques for studying bystander effects in vitro by high and low-LET ionising radiation. Radiat Prot Dosimetry (2006) 0.82
A case study of the Tenwek hospital community health programme in Kenya. Soc Sci Med (1989) 0.82
Alterations in lumbar cerebrospinal fluid protein during air encephalography. Br Med J (1970) 0.82
Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation. Adv Exp Med Biol (1997) 0.82
Sensitization of enteric neurons to morphine by HIV-1 Tat protein. Neurogastroenterol Motil (2015) 0.81
Effects of environmental factors on streptococcal erythrogenic toxin A (SPE A) production by Streptococcus pyogenes. Adv Exp Med Biol (1997) 0.81
The in vitro antibacterial activity of ceftriaxone against Streptococcus pyogenes is unrelated to penicillin-binding protein 4. FEMS Microbiol Lett (1993) 0.81
Pseudallescheria boydii arthritis and osteomyelitis in a patient with Cushing's disease. South Med J (1987) 0.81
Clinical and pathological effects of cigarette smoke exposure in beagle dogs. Arch Pathol Lab Med (1978) 0.81
Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium. J Pharmacol Exp Ther (1995) 0.81
Radiation-induced transformation of SV40-immortalized human thyroid epithelial cells by single exposure to plutonium alpha-particles in vitro. Int J Radiat Biol (1997) 0.81
Is the increased relative biological effectiveness of high LET particles due to spatial or temporal effects? Characterization and OER in V79-4 cells. Phys Med Biol (2002) 0.80
Group B streptococcal osteomyelitis in adults. South Med J (1978) 0.80
Amebic liver abscess. Report of a case presenting with nonreactive serologic tests for Entamoeba histolytica. Am J Gastroenterol (1979) 0.80
Streptococcal pyrogenic exotoxin A and streptolysin O enhance polymorphonuclear leukocyte binding to gelatin matrixes. J Infect Dis (1992) 0.79
Novel therapies in streptococcal toxic shock syndrome: attenuation of virulence factor expression and modulation of the host response. Curr Opin Infect Dis (1998) 0.79
Rapid screening for deletion mutations in the hprt gene using the polymerase chain reaction: X-ray and alpha-particle mutant spectra. Mutat Res (1992) 0.79
Investigation of the responsiveness of BCG-vaccinated children with whooping-cough to tuberculin. Int Arch Allergy Appl Immunol (1972) 0.79
Direct effects of purified staphylococcal toxic shock syndrome toxin 1 on myocardial function of isolated rabbit atria. Rev Infect Dis (1989) 0.79
Increased complexity of radiation-induced chromosome aberrations consistent with a mechanism of sequential formation. Cytogenet Genome Res (2006) 0.78
A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse. J Pharmacol Exp Ther (1992) 0.78
The history of Huntington's chorea. J R Coll Physicians Lond (1972) 0.78
Beta-adrenoceptor-mediated modulation of calcium ionophore activated polymorphonuclear leucocytes. Br J Pharmacol (1986) 0.78
Streptococcal toxic shock syndrome. Clin Microbiol Infect (2002) 0.78
Mycotic aneurysm and disseminated Mycobacterium avium-intracellulare infection in a patient with hairy cell leukemia. West J Med (1989) 0.77
Sequential computerized axial tomography in tuberculous meningitis. JAMA (1978) 0.77
Lung clearance of neutron-activated Mount St. Helens volcanic ash in the rat. Environ Res (1984) 0.77